vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and FIRST MID BANCSHARES, INC. (FMBH). Click either name above to swap in a different company.
FIRST MID BANCSHARES, INC. is the larger business by last-quarter revenue ($88.2M vs $62.1M, roughly 1.4× Cytek Biosciences, Inc.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs -70.9%, a 97.8% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 3.4%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 5.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
CTKB vs FMBH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $88.2M |
| Net Profit | $-44.1M | $23.7M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 34.0% |
| Net Margin | -70.9% | 26.8% |
| Revenue YoY | 8.1% | 3.4% |
| Net Profit YoY | -557.1% | 23.5% |
| EPS (diluted) | — | $0.98 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $88.2M | ||
| Q3 25 | $52.3M | $89.3M | ||
| Q2 25 | $45.6M | $87.5M | ||
| Q1 25 | $41.5M | $84.3M | ||
| Q4 24 | $57.5M | $85.3M | ||
| Q3 24 | $51.5M | $80.6M | ||
| Q2 24 | $46.6M | $79.2M | ||
| Q1 24 | $44.9M | $79.9M |
| Q4 25 | $-44.1M | $23.7M | ||
| Q3 25 | $-5.5M | $22.5M | ||
| Q2 25 | $-5.6M | $23.4M | ||
| Q1 25 | $-11.4M | $22.2M | ||
| Q4 24 | $9.6M | $19.2M | ||
| Q3 24 | $941.0K | $19.5M | ||
| Q2 24 | $-10.4M | $19.7M | ||
| Q1 24 | $-6.2M | $20.5M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 34.0% | ||
| Q3 25 | -17.6% | 32.2% | ||
| Q2 25 | -23.3% | 34.4% | ||
| Q1 25 | -36.1% | 33.4% | ||
| Q4 24 | 5.2% | 29.7% | ||
| Q3 24 | -8.2% | 31.5% | ||
| Q2 24 | -18.3% | 33.7% | ||
| Q1 24 | -23.9% | 33.7% |
| Q4 25 | -70.9% | 26.8% | ||
| Q3 25 | -10.5% | 25.2% | ||
| Q2 25 | -12.2% | 26.8% | ||
| Q1 25 | -27.5% | 26.3% | ||
| Q4 24 | 16.8% | 22.5% | ||
| Q3 24 | 1.8% | 24.2% | ||
| Q2 24 | -22.4% | 24.9% | ||
| Q1 24 | -13.8% | 25.6% |
| Q4 25 | — | $0.98 | ||
| Q3 25 | — | $0.94 | ||
| Q2 25 | — | $0.98 | ||
| Q1 25 | — | $0.93 | ||
| Q4 24 | — | $0.81 | ||
| Q3 24 | — | $0.81 | ||
| Q2 24 | — | $0.82 | ||
| Q1 24 | — | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | $354.5M |
| Stockholders' EquityBook value | $341.7M | $958.7M |
| Total Assets | $461.5M | $8.0B |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | — | $354.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $958.7M | ||
| Q3 25 | $378.6M | $932.2M | ||
| Q2 25 | $377.6M | $894.1M | ||
| Q1 25 | $379.6M | $870.9M | ||
| Q4 24 | $395.7M | $846.4M | ||
| Q3 24 | $385.5M | $858.5M | ||
| Q2 24 | $389.1M | $813.6M | ||
| Q1 24 | $392.6M | $798.0M |
| Q4 25 | $461.5M | $8.0B | ||
| Q3 25 | $494.9M | $7.8B | ||
| Q2 25 | $493.3M | $7.7B | ||
| Q1 25 | $482.6M | $7.6B | ||
| Q4 24 | $499.5M | $7.5B | ||
| Q3 24 | $491.2M | $7.6B | ||
| Q2 24 | $483.7M | $7.6B | ||
| Q1 24 | $492.1M | $7.7B |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $130.9M |
| Free Cash FlowOCF − Capex | $-1.8M | $124.0M |
| FCF MarginFCF / Revenue | -2.9% | 140.6% |
| Capex IntensityCapex / Revenue | 1.6% | 7.8% |
| Cash ConversionOCF / Net Profit | — | 5.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $207.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $130.9M | ||
| Q3 25 | $-3.9M | $33.0M | ||
| Q2 25 | $108.0K | $7.7M | ||
| Q1 25 | $-125.0K | $47.9M | ||
| Q4 24 | $2.0M | $124.4M | ||
| Q3 24 | $13.2M | $33.1M | ||
| Q2 24 | $6.2M | $24.0M | ||
| Q1 24 | $4.0M | $29.0M |
| Q4 25 | $-1.8M | $124.0M | ||
| Q3 25 | $-4.6M | $31.9M | ||
| Q2 25 | $-1.5M | $6.0M | ||
| Q1 25 | $-974.0K | $46.0M | ||
| Q4 24 | $1.1M | $119.5M | ||
| Q3 24 | $12.2M | $32.0M | ||
| Q2 24 | $5.2M | $22.9M | ||
| Q1 24 | $3.4M | $27.6M |
| Q4 25 | -2.9% | 140.6% | ||
| Q3 25 | -8.7% | 35.8% | ||
| Q2 25 | -3.2% | 6.8% | ||
| Q1 25 | -2.3% | 54.5% | ||
| Q4 24 | 1.9% | 140.0% | ||
| Q3 24 | 23.7% | 39.7% | ||
| Q2 24 | 11.0% | 28.9% | ||
| Q1 24 | 7.6% | 34.5% |
| Q4 25 | 1.6% | 7.8% | ||
| Q3 25 | 1.3% | 1.2% | ||
| Q2 25 | 3.5% | 2.0% | ||
| Q1 25 | 2.0% | 2.3% | ||
| Q4 24 | 1.6% | 5.8% | ||
| Q3 24 | 2.0% | 1.4% | ||
| Q2 24 | 2.3% | 1.4% | ||
| Q1 24 | 1.3% | 1.9% |
| Q4 25 | — | 5.53× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 2.16× | ||
| Q4 24 | 0.21× | 6.49× | ||
| Q3 24 | 14.05× | 1.70× | ||
| Q2 24 | — | 1.21× | ||
| Q1 24 | — | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FMBH
Segment breakdown not available.
